Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

exendin

  • Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
    You have access
    Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
    Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 794-800; DOI: https://doi.org/10.2967/jnumed.121.262506
  • Open Access
    Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
    Marti Boss, Desiree Bos, Cathelijne Frielink, Gerwin Sandker, Patricia Bronkhorst, Sanne A.M. van Lith, Maarten Brom, Mijke Buitinga and Martin Gotthardt
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1588-1593; DOI: https://doi.org/10.2967/jnumed.119.238998
  • Open Access
    Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
    Marti Boss, Desiree Bos, Cathelijne Frielink, Gerwin Sandker, Selen Ekim, Camille Marciniak, Francois Pattou, Go van Dam, Sanne van Lith, Maarten Brom, Martin Gotthardt and Mijke Buitinga
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 1066-1071; DOI: https://doi.org/10.2967/jnumed.119.234542
  • You have access
    Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes
    Eshita Khera, Liang Zhang, Sheryl Roberts, Ian Nessler, Darleen Sandoval, Thomas Reiner and Greg M. Thurber
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1635-1641; DOI: https://doi.org/10.2967/jnumed.118.224881
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire